INIS
coronaviruses
100%
viruses
64%
transmission
61%
universities
48%
diseases
33%
testing
30%
dynamics
30%
tools
29%
rna
25%
host
24%
comparative evaluations
23%
medical centers
23%
populations
23%
surveillance
22%
vaccines
20%
transcription
20%
proteins
20%
patients
19%
pathogens
19%
humans
17%
workers
17%
doses
17%
tissues
16%
panels
14%
lungs
14%
public health
14%
pcr
14%
values
13%
macrophages
13%
cell cultures
12%
resolution
12%
antibodies
12%
data
12%
polymerase chain reaction
11%
immunity
11%
heat
11%
mice
11%
protection
11%
genes
11%
detection
11%
urine
11%
epidemiology
11%
education
11%
inactivation
11%
infants
11%
concentration
11%
strains
11%
travel
11%
splicing
11%
communities
10%
Keyphrases
University Population
11%
Unstable Housing
11%
COVID-19
11%
Urban Universities
11%
Sample Quality
11%
Heat Inactivation
11%
Macrophages
11%
Gene Signature
11%
SARS-CoV-2 Infection
11%
BinaxNOW
11%
Single-cell RNA Sequencing (scRNA-seq)
11%
Sarbecoviruses
11%
Anterior Nares
11%
Infant Urine
11%
Human Lung Tissue
11%
MAb114
11%
Viral Host
11%
Nipah Virus
11%
Public Health Mandates
11%
Tissue Protection
11%
Close Contact
11%
Humanized Mice
11%
Soccer Clubs
11%
Major League Soccer
11%
Pfizer-BioNTech
11%
Viral
11%
ZsGreen
11%
Protein Splicing
11%
RadA
9%
Mica
8%
Time to Culture Conversion
7%
Biosafety Level 4
6%
Virus Inactivation
6%
5′-end
6%
VP30
6%
In-person Learning
5%
Fetal Lung
5%
Human Immune System
5%
University Environment
5%
India
5%
Unvaccinated
5%
Delta Variant
5%
Lung Tissue
5%
Human Fetus
5%
Anti-B Cell Therapy
5%
Robust Transmission
5%
Xenograft
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
94%
Infection
21%
COVID-19
19%
Cohort Analysis
14%
Contact Examination
14%
Diagnosis
13%
Public Health
13%
Macrophage
11%
Omicron Coronavirus Variant
11%
Culture Conversion
11%
Genomic Epidemiology
11%
Reinfection
11%
Symptom
11%
Reverse Transcription Polymerase Chain Reaction
10%
Sensitivity and Specificity
7%
Whole Genome Sequencing
6%
Coronavirinae
5%
Infection Control
5%
